Holdings
Davern Capital Partners, LP
As of Sep 30, 2026, Davern Capital Partners, LP reported 16 positions worth US$457M. Largest: BioNTech SE, Insmed Incorporated and Roivant Sciences Ltd. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| BioNTech SE | 682K | US$67.1M | new | Sep 30, 2026 |
| Insmed Incorporated | 496K | US$56.6M | −63,777 | Sep 30, 2026 |
| Roivant Sciences Ltd. | 1.47M | US$53.9M | −460K | Sep 30, 2026 |
| Ionis Pharmaceuticals, Inc. | 1.09M | US$48.5M | +288K | Sep 30, 2026 |
| argenx SE | 37,597 | US$36.1M | new | Sep 30, 2026 |
| Regeneron Pharmaceuticals, Inc. | 40,661 | US$30.8M | −51,979 | Sep 30, 2026 |
| Natera, Inc. | 63,200 | US$26.1M | −55,775 | Sep 30, 2026 |
| Abivax SA | 219K | US$21.7M | new | Sep 30, 2026 |
| Vera Therapeutics, Inc. | 628K | US$20.3M | +129K | Sep 30, 2026 |
| Mineralys Therapeutics, Inc. | 695K | US$17.5M | −164K | Sep 30, 2026 |